TP53 R248Q TCR-T Cell Therapy

· Shanghai General Hospital; Shanghai Jiao Tong University School of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TP53 R248Q TCR-T Cell Therapy, covering 2024-10-01 to 2024-10-01. Get the full timeline:

Most recent: Clinical Trial Update: TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor [EARLY_Phase 1]